Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 23:12:699062.
doi: 10.3389/fphar.2021.699062. eCollection 2021.

The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives

Affiliations

The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives

Valeria Belleudi et al. Front Pharmacol. .

Abstract

There is an acute need for research to acquire high-quality information on the use of medicines in pregnancy, both in terms of appropriateness and safety. For this purpose, the Italian Medicines Agency established a Network for Monitoring Medication use in pregnancy (MoM-Net) through the conduction of population-based studies using administrative data available at regional level. This paper aimed to describe the experiences and challenges within the network. MoM-Net currently involves eight regions and several experts from public and academic institutions. The first study conducted aimed to identify drug use before, during and after pregnancy investigating specific therapeutic categories, analysing regional variability and monitoring drug use in specific subpopulations (i.e. foreign women/multiple pregnancies). Aggregated demographic, clinical, and prescription data were analysed using a distributed network approach based on common data model. The study population included all women delivering during 2016-2018 in the participating regions (n = 449,012), and corresponding to 59% of deliveries in Italy. Seventy-three per cent of the cohort had at least one drug prescription during pregnancy, compared to 57% before and 59% after pregnancy. In general, a good adherence to guidelines for pregnant women was found although some drug categories at risk of inappropriateness, such as progestins and antibiotics, were prescribed. A strong variability in the use of drugs among regions and in specific subpopulations was observed. The MoM-Net represents a valuable surveillance system on the use of medicines in pregnancy, available to monitor drug categories at high risk of inappropriateness and to investigate health needs in specific regions or subpopulations.

Keywords: appropriateness; medication use; monitoring; network; pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Analytical approach used to execute observational studies within the network MoM-Net.
FIGURE 2
FIGURE 2
Sankey diagram used to describe the pattern of drug use in different trimesters of pregnancy: the example of antihypertensive in women with prevalent use during pregnancy.
FIGURE 3
FIGURE 3
Sankey diagram used to describe the pattern of drug use in different trimesters of pregnancy: the example of antihypertensive in women with incident use in pregnancy.

References

    1. Allotey J., Stallings E., Bonet M., Yap M., Chatterjee S., Kew T., et al. (2020). Clinical Manifestations, Risk Factors, and Maternal and Perinatal Outcomes of Coronavirus Disease 2019 in Pregnancy: Living Systematic Review and Meta-Analysis. BMJ 370, m3320. 10.1136/bmj.m3320 - DOI - PMC - PubMed
    1. Andrade S. E., Toh S., Houstoun M., Mott K., Pitts M., Kieswetter C., et al. (2016). Surveillance of Medication Use During Pregnancy in the Mini-Sentinel Program. Matern. Child. Health J. 20 (4), 895–903. 10.1007/s10995-015-1878-8 - DOI - PubMed
    1. AuthorAnonymous (1992). Medication during Pregnancy: an Intercontinental Cooperative Study. Collaborative Group on Drug Use in Pregnancy (C.G.D.U.P.). Int. J. Gynaecol. Obstet. 39 (3), 185–196. - PubMed
    1. Benevent J., Araujo M., Hurault-Delarue C., Montastruc J.-L., Sommet A., Lacroix I., et al. (2019). Pharmacoepidemiology in Pregnancy. Therapies 74 (2), 289–300. 10.1016/j.therap.2018.11.014 - DOI - PubMed
    1. Bérard A., Abbas-Chorfa F., Kassai B., Vial T., Nguyen K. A., Sheehy O., et al. (2019). The French Pregnancy Cohort: Medication Use during Pregnancy in the French Population. PLoS One 14, e0219095. 10.1371/journal.pone.0219095 - DOI - PMC - PubMed

LinkOut - more resources